Brandon Imber, MD, MS

Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures:

  • Employment: Memorial Sloan Kettering Cancer Center:Assistant Attending Radiation Oncologist:Employee
  • Compensation: GT Medical Technologies: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Honoraria-End Date: to present ;Telix Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: November 2022 ;AstraZeneca: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: to present ;Novartis: Research Grants, Research Funding, Research Salary Support, Research Role Description-End Date: to pr
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

When, How, and Why Should We Use Very Low Dose RT in Indolent Lymphomas?
Room 152
08:17am - 08:32am PT
Sep 30

331 - Prospective Study of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cells for Relapsed/Refractory B-Cell Lymphomas
Room 314
02:50pm - 03:00pm PT